中文 | English
Return
Total: 50 , 1/5
Show Home Prev Next End page: GO
Author:(Shengqiang LIU)

1.Efficacy and Safety of Qixian Tongluo Formula in the Treatment of Post-Cerebral Infarction Paralysis with Kidney Deficiency and Blood Stasis Syndrome:A Pragmatic Randomized Controlled Trial and Preliminary Exploration of miRNA Cross-Kingdom Regulation Mechanism

Shengqiang ZHOU ; Yanjun CHEN ; Guo MAO ; Wen ZENG ; Jia HUANG ; Zhixin LI ; Jintao XIAO ; Ruizhen WANG ; Lingjuan TAN ; Fang LIU

World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(4):1120-1130

2.Impact of extracellular HSP22 on TLR4/NF-κB signaling pathway in ox-LDL induced coronary artery endothelial cell inflammatory injury

Shengqiang ZENG ; Yanqing WU ; Liu YANG ; Yuqin XU

Chongqing Medicine 2025;54(2):297-302

3.Study on the Mechanism of Shenqi Xiaozheng Decoction-Medicated Serum in Inhibiting Glutamine Metabolism and Activating Immunogenic Cell Death in Lung Cancer Cells via c-Myc/SLC1A5/GLS1 Signaling Axis

Lingjuan TAN ; Shengqiang ZHOU ; Wen ZENG ; Xiaolan JIAN ; Kexiong LI ; Fang LIU

Chinese Journal of Information on Traditional Chinese Medicine 2025;32(11):112-122

4.A modular total sacral prosthesis for reconstruction after total sacrectomy: finite element analysis and effectiveness evaluation

Dongxiao BIAN ; Jie ZANG ; Siyi HUANG ; Ning LIU ; Shengqiang LIU ; Xiaodong TANG

Chinese Journal of Orthopaedics 2025;45(14):946-953

5.A modular total sacral prosthesis for reconstruction after total sacrectomy: finite element analysis and effectiveness evaluation

Dongxiao BIAN ; Jie ZANG ; Siyi HUANG ; Ning LIU ; Shengqiang LIU ; Xiaodong TANG

Chinese Journal of Orthopaedics 2025;45(14):946-953

6.Study on the Mechanism of Shenqi Xiaozheng Decoction-Medicated Serum in Inhibiting Glutamine Metabolism and Activating Immunogenic Cell Death in Lung Cancer Cells via c-Myc/SLC1A5/GLS1 Signaling Axis

Lingjuan TAN ; Shengqiang ZHOU ; Wen ZENG ; Xiaolan JIAN ; Kexiong LI ; Fang LIU

Chinese Journal of Information on Traditional Chinese Medicine 2025;32(11):112-122

7.Efficacy and Safety of Qixian Tongluo Formula in the Treatment of Post-Cerebral Infarction Paralysis with Kidney Deficiency and Blood Stasis Syndrome:A Pragmatic Randomized Controlled Trial and Preliminary Exploration of miRNA Cross-Kingdom Regulation Mechanism

Shengqiang ZHOU ; Yanjun CHEN ; Guo MAO ; Wen ZENG ; Jia HUANG ; Zhixin LI ; Jintao XIAO ; Ruizhen WANG ; Lingjuan TAN ; Fang LIU

World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(4):1120-1130

8.Research progress of screening tools for palliative care needs in emergency patients before referral at home and abroad

Xuefei WU ; Shengqiang ZOU ; Chunhua GE ; Changfeng MAN ; Jiahui LI ; Jing XIE ; Xiyang LIU

Chinese Journal of Nursing 2024;59(14):1786-1793

9.Effect and Mechanism of Qixian Tongluo Formula on Contralateral Corticospinal Tract Remodeling and Motor Functional Recovery in Rats with Cerebral Infarction

Shengqiang ZHOU ; Dahua WU ; Bo LI ; Yanjun CHEN ; Jia HUANG ; Qi WANG ; Wen ZENG ; Lingjuan TAN ; Yihui DENG ; Fang LIU

Traditional Chinese Drug Research & Clinical Pharmacology 2024;35(9):1319-1328

10.Exploration on innovative education model of the integration of medicine and science for applied psychology major in medical colleges under the background of "New Medicine"

Xinyan MA ; Yanmin PU ; Yutong YING ; Herui SHANG ; Shengqiang CHEN ; Sha LIU ; Xueqin ZHANG

Chinese Journal of Medical Education Research 2024;23(7):877-881

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 50 , 1/5 Show Home Prev Next End page: GO